Next Article in Journal
Barriers to the Access and Use of Rituximab in Patients with Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia: A Physician Survey
Next Article in Special Issue
Development and Successful Validation of Simple and Fast TLC Spot Tests for Determination of Kryptofix® 2.2.2 and Tetrabutylammonium in 18F-Labeled Radiopharmaceuticals
Previous Article in Journal
Enhanced Antimicrobial Activity of AamAP1-Lysine, a Novel Synthetic Peptide Analog Derived from the Scorpion Venom Peptide AamAP1
Previous Article in Special Issue
In Vivo Monitoring of the Antiangiogenic Effect of Neurotensin Receptor-Mediated Radiotherapy by Small-Animal Positron Emission Tomography: A Pilot Study
 
 
Article

Article Versions Notes

Pharmaceuticals 2014, 7(5), 517-529; https://doi.org/10.3390/ph7050517
Action Date Notes Link
article pdf uploaded. 29 April 2014 13:58 CEST Version of Record https://www.mdpi.com/1424-8247/7/5/517/pdf-vor
article pdf uploaded. 5 May 2014 15:30 CEST Updated version of record https://www.mdpi.com/1424-8247/7/5/517/pdf
article xml file uploaded 5 June 2014 08:48 CEST Original file -
article html file updated 5 June 2014 08:48 CEST Original file -
article xml file uploaded 5 June 2014 09:43 CEST Update -
article html file updated 5 June 2014 09:43 CEST Update -
article xml file uploaded 5 June 2014 09:43 CEST Update https://www.mdpi.com/1424-8247/7/5/517/xml
article html file updated 5 June 2014 09:43 CEST Update -
article html file updated 20 August 2015 05:02 CEST Update -
article html file updated 21 March 2019 16:17 CET Update -
article html file updated 7 May 2019 15:13 CEST Update -
article html file updated 6 February 2020 08:55 CET Update https://www.mdpi.com/1424-8247/7/5/517/html
Back to TopTop